WAT logo

WAT

Research Snapshot

Static fundamentals, valuation context, and investor signals for Waters Corporation (WAT).

HEALTHCARE
DIAGNOSTICS & RESEARCH
DCF ready

Valuation

N/A

EV/FCF, N/A FCF yield

Quality

16.2%

ROIC, 17.1% FCF margin

Growth

6.0%

5Y sales (revenue) CAGR

Balance sheet

0.6x

Debt/equity, 1.7x current ratio

Superinvestors

8

Top: Terry Smith (7.5%)

Strengths to research

  • Return on equity is strong at 25.1%.
  • Free cash flow margin is healthy at 17.1%.
  • Debt/equity looks manageable at 0.6x.
  • 8 tracked superinvestors report a position.

Watchouts

  • Valuation multiples are limited or unavailable.
Annual data: 10 periods
Quarterly data: 21 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for WAT.

Grade D
40
/ 100

Financial Charts

No financial data available for WAT (annual).

8 superinvestors own WAT

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
Terry Smith

Fundsmith

3,212,075$957M7.46%0.0%
First Eagle Investment Management

First Eagle Investment Management

1,575,187$469M0.80%0.0%
Viking Global Investors

Viking Global Investors

1,256,462$374M1.05%0.0%
Nicolai Tangen

AKO Capital

816,929$243M4.76%0.0%
Bill Nygren

Oakmark Select Fund

288,712$86M0.11%0.0%
Jensen Investment Management

Jensen Investment Management

38,766$12M0.23%0.0%
Robert Olstein

Olstein Capital Management

10,000$3M0.65%0.0%
Mairs & Power Growth Fund

Mairs & Power Growth Fund

958$286,0000.00%0.0%